GlassScriptPhysician profile
Anupam Halder
NPI 1972187763
$2,752.61
in general payments reported to CMS, 2019-2025
10 companies · $2,452 in 2025
The $2,452 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $301 · 2025: $2,452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,334 · Travel and Lodging: $1,257 · Education: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,333.70 |
| Travel and Lodging | $1,257.42 |
| Education | $161.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,135.68 | 2025 | Gallant, Ensite |
| Medtronic, INC. | $180.81 | 2024-2025 | Onyx Frontier, Mycarelink |
| Abiomed | $135.56 | 2024-2025 | Impella |
| Boston Scientific Corporation | $102.72 | 2025 | Watchman Flx |
| Bayer Healthcare Pharmaceuticals INC. | $55.00 | 2025 | |
| Novartis Pharmaceuticals Corporation | $42.58 | 2024-2025 | |
| Actelion Pharmaceuticals US, INC. | $34.00 | 2025 | Opsumit, Uptravi |
| Cleerly, INC. | $25.00 | 2025 | Cleerly Labs, Cleerly Ischemia |
| E.R. Squibb & Sons, L.L.C. | $21.24 | 2025 | Camzyos |
| Amgen INC. | $20.02 | 2024 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anupam Halder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.